Net Income (Loss) Attributable to Parent in USD of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2010 to Q3 2025.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Net Income (Loss) Attributable to Parent for the quarter ending 27 Sep 2025 was $54.4M, a 21.9% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 27 Sep 2025 was -$82.3M, a 119% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Net Income (Loss) Attributable to Parent for 2024 was $22.2M, a 95.3% decline from 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Net Income (Loss) Attributable to Parent for 2023 was $475M, a 2.39% decline from 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. annual Net Income (Loss) Attributable to Parent for 2022 was $486M, a 24.4% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$82.3M $54.4M -$15.2M -21.9% 29 Jun 2025 27 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$67M $52.3M -$41.8M -44.4% 30 Mar 2025 28 Jun 2025 10-Q 06 Aug 2025
Q1 2025 -$25.3M $25.5M -$47.5M -65.1% 29 Dec 2024 29 Mar 2025 10-Q 07 May 2025
Q4 2024 $22.2M -$214M -$402M -215% 29 Sep 2024 28 Dec 2024 10-K 19 Feb 2025
Q3 2024 $424M $69.7M -$17.7M -20.3% 30 Jun 2024 28 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $442M $94.1M -$2.94M -3.03% 31 Mar 2024 29 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $444M $73M -$30.2M -29.3% 31 Dec 2023 30 Mar 2024 10-Q 07 May 2025
Q4 2023 $475M $187M -$326K -0.17% 01 Oct 2023 30 Dec 2023 10-K 19 Feb 2025
Q3 2023 $475M $87.4M -$9.08M -9.42% 02 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $484M $97M -$12.3M -11.3% 02 Apr 2023 01 Jul 2023 10-Q 07 Aug 2024
Q1 2023 $496M $103M +$10.1M +10.9% 01 Jan 2023 01 Apr 2023 10-Q 09 May 2024
Q4 2022 $486M $187M +$49.8M +36.2% 25 Sep 2022 31 Dec 2022 10-K 19 Feb 2025
Q3 2022 $436M $96.5M -$6.95M -6.72% 26 Jun 2022 24 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $443M $109M +$20.9M +23.6% 27 Mar 2022 25 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $422M $93M +$31.5M +51.2% 26 Dec 2021 26 Mar 2022 10-Q 11 May 2023
Q4 2021 $391M $138M -$5.61M -3.92% 26 Sep 2021 25 Dec 2021 10-K 14 Feb 2024
Q3 2021 $397M $103M +$517K +0.5% 27 Jun 2021 25 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $396M $88.4M +$21M +31.2% 28 Mar 2021 26 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $375M $61.5M +$10.8M +21.2% 27 Dec 2020 27 Mar 2021 10-Q 04 May 2022
Q4 2020 $364M $143M +$62.8M +78.2% 27 Sep 2020 26 Dec 2020 10-K 17 Feb 2021
Q3 2020 $301M $103M +$30.1M +41.3% 28 Jun 2020 26 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $271M $67.4M +$23.7M +54.2% 29 Mar 2020 27 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $248M $50.8M -$4.36M -7.92% 29 Dec 2019 28 Mar 2020 10-Q 04 May 2021
Q4 2019 $252M $80.3M +$20.7M +34.7% 29 Sep 2019 28 Dec 2019 10-K 17 Feb 2021
Q3 2019 $231M $72.8M +$12.4M +20.6% 30 Jun 2019 28 Sep 2019 10-K 17 Feb 2021
Q2 2019 $219M $43.7M -$9.98M -18.6% 31 Mar 2019 29 Jun 2019 10-K 17 Feb 2021
Q1 2019 $229M $55.1M +$2.5M +4.75% 30 Dec 2018 30 Mar 2019 10-K 17 Feb 2021
Q4 2018 $226M $59.7M +$89.5M 30 Sep 2018 29 Dec 2018 10-K 11 Feb 2020
Q3 2018 $137M $60.4M +$7.89M +15% 01 Jul 2018 29 Sep 2018 10-K 11 Feb 2020
Q2 2018 $129M $53.7M -$243K -0.45% 01 Apr 2018 30 Jun 2018 10-K 11 Feb 2020
Q1 2018 $129M $52.6M +$5.85M +12.5% 31 Dec 2017 31 Mar 2018 10-K 11 Feb 2020
Q4 2017 $123M -$29.8M -$74.5M -167% 01 Oct 2017 30 Dec 2017 10-K 13 Feb 2019
Q3 2017 $198M $52.5M +$14.7M +39.1% 02 Jul 2017 30 Sep 2017 10-K 13 Feb 2019
Q2 2017 $183M $54M +$18.7M +53.2% 02 Apr 2017 01 Jul 2017 10-K 13 Feb 2019
Q1 2017 $164M $46.8M +$9.64M +25.9% 01 Jan 2017 01 Apr 2017 10-K 13 Feb 2019
Q4 2016 $155M $44.7M +$12.8M +40.1% 25 Sep 2016 31 Dec 2016 10-K 13 Feb 2019
Q3 2016 $142M $37.7M +$356K +0.95% 26 Jun 2016 24 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $142M $35.2M -$13.3M -27.4% 27 Mar 2016 25 Jun 2016 10-Q 09 Aug 2017
Q1 2016 $155M $37.1M +$5.6M +17.8% 27 Dec 2015 26 Mar 2016 10-Q 10 May 2017
Q4 2015 $149M $31.9M 27 Sep 2015 26 Dec 2015 10-K 13 Feb 2018
Q3 2015 $37.4M 28 Jun 2015 26 Sep 2015 10-Q 02 Nov 2016
Q2 2015 $48.5M 29 Mar 2015 27 Jun 2015 10-Q 03 Aug 2016
Q1 2015 $31.5M 28 Dec 2014 28 Mar 2015 10-Q 04 May 2016
Q2 2011 -$305M $32.3M +$17.9M +124% 27 Mar 2011 25 Jun 2011 10-Q 03 Aug 2011
Q1 2011 -$323M $31.3M +$14M +80.3% 26 Dec 2010 26 Mar 2011 10-Q 04 May 2011
Q4 2010 -$337M -$344M 26 Sep 2010 25 Dec 2010 10-K 23 Feb 2011
Q3 2010 -$24.9M 27 Jun 2010 25 Sep 2010 10-Q 04 Nov 2010
Q2 2010 $14.5M 28 Mar 2010 26 Jun 2010 10-Q 03 Aug 2011
Q1 2010 $17.4M 27 Dec 2009 27 Mar 2010 10-Q 04 May 2011

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $22.2M -$452M -95.3% 31 Dec 2023 28 Dec 2024 10-K 19 Feb 2025
2023 $475M -$11.6M -2.39% 01 Jan 2023 30 Dec 2023 10-K 19 Feb 2025
2022 $486M +$95.2M +24.4% 26 Dec 2021 31 Dec 2022 10-K 19 Feb 2025
2021 $391M +$26.7M +7.32% 27 Dec 2020 25 Dec 2021 10-K 14 Feb 2024
2020 $364M +$112M +44.6% 29 Dec 2019 26 Dec 2020 10-K 22 Feb 2023
2019 $252M +$25.6M +11.3% 30 Dec 2018 28 Dec 2019 10-K 16 Feb 2022
2018 $226M +$103M +83.5% 31 Dec 2017 29 Dec 2018 10-K 17 Feb 2021
2017 $123M -$31.4M -20.3% 01 Jan 2017 30 Dec 2017 10-K 11 Feb 2020
2016 $155M +$5.45M +3.65% 27 Dec 2015 31 Dec 2016 10-K 13 Feb 2019
2015 $149M +$22.6M +17.9% 28 Dec 2014 26 Dec 2015 10-K 13 Feb 2018
2014 $127M +$23.9M +23.2% 29 Dec 2013 27 Dec 2014 10-K 14 Feb 2017
2013 $103M 30 Dec 2012 28 Dec 2013 10-K 12 Feb 2016
2010 -$337M 27 Dec 2009 25 Dec 2010 10-K 23 Feb 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.